Ivermectin Meta-Analysis Demonstrating Safety & Efficacy Targeting COVID-19 Published in Peer-Review Journal

Ivermectin Meta-Analysis Demonstrating Safety & Efficacy Targeting COVID-19 Published in Peer-Review Journal

Led by physicians affiliated with the Front Line COVID-19 Critical Care Alliance (FLCCC), a meta-analysis of 18 randomized controlled trials involving the generic drug ivermectin reveals a statistically significant reduction in mortality, time to clinical recovery, and time to viral clearance. The study, led by a group of dedicated front-line physician/researchers, also found that the results from a number of controlled prophylaxis studies indicate that the regular use of this economical, generic drug led to significant reduction of risk involving the transmission of SARS-CoV-2, the virus behind COVID-19. The authors showcase a number of public and privately funded ivermectin distribution programs that appear to correlate with population-wide decreases in morbidity and mortality. Does this meta-analysis indicate that ivermectin should be embraced as a primary research as a care option approach for early onset, mild-to-moderate COVID-19? How about additional prophylaxis studies? While mounting data indicates an overwhelmingly positive outlook, regulators, national research institutes, the World Health Organization (WHO), and the pharmaceutical industry have opted to take a “glass h...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee